ESC 365 - Welcome/Opening - What have we learned from SGLT-2 inhibitors in heart failure?

Open Access

Welcome/Opening - What have we learned from SGLT-2 inhibitors in heart failure?

Session: What have we learned from SGLT-2 inhibitors in heart failure?

Topic: Other

Speaker: Professor S. Kang (Seoul, KR)

Sponsored by Boehringer Ingelheim

Event: ESC Asia with APSC & AFC 2020

Congress Presentation

Add to my library

About the speaker

Professor Seok Min Kang

Yonsei University, Seoul (Korea (Republic of))

5 presentations

0 follower

3 more presentations in this session

What have we learned from SGLT-2 Inhibitors in Heart Failure?

Speaker: Professor R. Fontes Carvalho (Vila Nova de Gaia, PT)

Q&A - What have we learned from SGLT-2 inhibitors in heart failure?

Speaker: Professor S. Kang (Seoul, KR) Professor R. Fontes Carvalho (Vila Nova de Gaia, PT)

Closing/Conclusion - What have we learned from SGLT-2 inhibitors in heart failure?

Speaker: Professor S. Kang (Seoul, KR)

Access the full session

What have we learned from SGLT-2 inhibitors in heart failure?

Speakers: Professor S. Kang, Professor R. Fontes Carvalho, Professor S. Kang, Professor R. Fontes Carvalho, Professor S. Kang

About the event

ESC Asia with APSC & AFC 2020

3 December - 5 December 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources